Canada Markets closed

Koninklijke Philips N.V. (PHG)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
32.62+0.44 (+1.37%)
At close: 04:00PM EST
32.62 +0.00 (+0.02%)
After hours: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close32.18
Open32.15
Bid32.61 x 900
Ask32.62 x 800
Day's Range31.93 - 32.63
52 Week Range31.34 - 61.23
Volume1,645,496
Avg. Volume1,830,762
Market Cap28.769B
Beta (5Y Monthly)0.79
PE Ratio (TTM)7.00
EPS (TTM)4.66
Earnings DateN/A
Forward Dividend & Yield1.03 (2.74%)
Ex-Dividend DateMay 10, 2021
1y Target Est59.50
  • GlobeNewswire

    Philips and University Hospital Brandenburg an der Havel sign 10-year partnership to advance patient care

    University Hospital Brandenburg an der Havel January 28, 2022 Major German University Hospital secures long-term access to the latest health technology through renewal of diagnostic and image-guided therapy solutionsPhilips to deliver new and upgraded hybrid operating room and interventional suitesAgreement includes training and education for hospital’s clinicians and medical technologists Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, an

  • Reuters

    UPDATE 3-U.S. FDA labels Philips expanded ventilator recall as most serious

    The U.S. Food and Drug Administration (FDA) on Wednesday classified an expanded recall of certain ventilators by Philips late last year as Class 1, or the most serious type, saying they could lead to injuries or death. The Dutch medical equipment company initiated the recall of 215 Trilogy Evo ventilators and 51 repair kits in the United States in December due to potential health risks from a type of foam used in the devices. So far, there have been no reported injuries or deaths from the products, which were distributed in the United States and Korea, the FDA said.

  • GlobeNewswire

    Philips introduces first at-home, 12-lead ECG integrated solution for decentralized clinical trials

    Philips introduces first at-home, 12 lead ECG integrated solution for decentralized clinical trials Philips new at-home, 12 lead ECG solution helps to reduce need for site visits during clinical trials January 26, 2022 Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during clinical trials Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a g